The career of Edward J. Benz Jr., MD, FEL ’79, now spanning nearly five decades, has been nothing short of remarkable. His list of leadership positions and accomplishments is far too long to enumerate here but includes serving as president and CEO of Dana-Farber Cancer Institute for 16 years, a professor at Harvard Medical School, physician-in-chief at Johns Hopkins Hospital, and chairman of the Department of Medicine at Johns Hopkins University School of Medicine.
Benz credits Yale School of Medicine (YSM), his first employer post-training, with unlocking his leadership skills and providing multiple opportunities to grow as he launched his career in academic medicine.
Career-Shaping Argument With a Catholic Nun
When Benz entered high school, becoming a physician was the furthest thing from his mind. Baseball was his passion. “I grew up hoping that I would become a first baseman for the Pittsburgh Pirates,” he says.
His interests shifted, however, in 10th grade after he got into an argument with his biology teacher, a Catholic nun, about how many chromosomes humans have. The nun said 48. Upon hearing this figure, Benz’s father, a pathologist, told his son that the correct number was 46. Benz pointed this out to his teacher, which led to an argument with her.
He recounts, “She did not take my impertinence lightly and made me write in my copy book 500 times ‘Man has 48 chromosomes’ and go to confession. When she asked me what I told the priest, I said that according to the seal of the confessional, I was not supposed to tell her that. But she insisted, so I said that I told the priest that I lied 500 times.”
This little clash sparked Benz’s interest in genetics. “I went to the library and looked up chromosome stuff,” he recalls. Given the exciting discoveries emerging surrounding DNA and RNA in 1961, Benz was intrigued. “All of a sudden you could make sense of how diversity in biology was happening. I realized that it was because of the way genes are regulated.”
Benz fell in love with molecular genetics. In medical school at Harvard, he found that one of the few disciplines where one could pursue this line of study was hematology. Thus, he chose to focus on and specialize in this field. “I just love the field of hematology,” he says, adding that a lecturer of his made the compelling argument that blood was the window of science into clinical medicine.
Benz remains excited by hematology. He notes, “Any molecule controlling how blood can clot sits in hematology—along with all the different cells that circulate in the blood, including stem cells. It’s at the cutting edge of science. And given the new technologies that can be applied today, this field is getting more and more exciting.”
Leadership Foundation
Benz navigated to YSM via hematologist Bernard Forget, MD, with whom Benz had worked on breakthrough research in sickle cell disease and thalassemia at Boston Children’s Hospital during a research year he took during medical school. Forget subsequently joined Yale as hematology section chief, and Benz, who was pursuing his postdoctoral fellowship at the NIH, followed. At YSM, Benz completed his fellowship and then served on the faculty, enjoying life in New Haven for the 15 years spanning from 1978 to 1993.